Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Why Investors Are Watching These Healthcare Movers
GlobeNewswire, Inc.
DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- (https://247mnn.com/) – ClearOne (NASDAQ: CLRO), NeOnc Technologies (NASDAQ: NTHI), Iovance Biotherapeutics (NASDAQ:IOVA), and Ensysce Biosciences (NASDAQ:ENSC) are covered in today’s roundup.
Switzerland extends its lead in the technologies reshaping the global economy
GlobeNewswire, Inc.
Zurich, June 17, 2026 (GLOBE NEWSWIRE) -- The technologies now driving the global economy, from advanced computing to artificial intelligence and robotics, are built patiently, over decades of sustained investment and deep scientific groundwork....
Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027
GlobeNewswire, Inc.
BASEL, Switzerland, July 30, 2026 (GLOBE NEWSWIRE) -- Questex, the owners of Fierce Pharma and Fierce Pharma Week, today announces the launch of a new annual event dedicated to the business of pharma.
Release Therapeutics Secures Innosuisse Funding to Expand Encapsulated Cell Technology for Sanfilippo Syndrome Type IIIA
EIN Presswire
The competitive funding reflects confidence in the translational potential of the Company’s platform, supporting its expansion into a second rare CNS indication GENEVA, SWITZERLAND, October 22, 2026 /EINPresswire.com/ -- Campus Innovation Park —...
Gieni ABX Brings Autonomous Organizational Health Checks to Salesforce Environments
GlobeNewswire, Inc.
ZURICH, July 28, 2026 (GLOBE NEWSWIRE) -- Gieni AG, the company behind Gieni ABX (Autonomous Business Execution), today announced that its ABX platform now delivers automated organizational health checks via a new Salesforce connection that...
Swiss-Rooted Longevity Brands Gain Attention as China’s Premium Wellness Consumers Look Beyond Origin Labels
EIN Presswire
64K Cellssense highlights its Swiss research, manufacturing context and European wellness network as beauty-from-within grows in China.
Swiss Referendum on Population Cap Sparks Immigration Debate
MENAFN
(MENAFN) Switzerland is voting on Sunday in a referendum over a controversial proposal that would limit the country’s population to 10 million, a move that has intensified debate over immigration and national resources.
Top 10 Private Label Skincare Manufacturers in 2026: Advancing Custom Beauty Solutions
EIN Presswire
A 2026 guide to ten private label skincare manufacturers.
![[Latest] Pharma 4.0 Market Size Expected to Reach USD 90.71 Billion by 2034, With 19.80% CAGR; Digital Transformation Initiatives, Regulatory Data Integrity Mandates, and Smart Manufacturing Needs to Propel Market Growth](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/18574987-652842201-zion-market-research-jpg-100x100.jpeg)
[Latest] Pharma 4.0 Market Size Expected to Reach USD 90.71 Billion by 2034, With 19.80% CAGR; Digital Transformation Initiatives, Regulatory Data Integrity Mandates, and Smart Manufacturing Needs to Propel Market Growth
GlobeNewswire, Inc.
NEW YORK, USA, July 21, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Pharma 4.0 Market By Technology (Artificial Intelligence and Machine Learning, Internet of Things, Big Data Analytics, Cloud...
Swiss Papers AG Launches Obsidio for Realistic DDoS Resilience Testing
EIN Presswire
Innovative Swiss security technology against global cyber threats.
HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
GlobeNewswire, Inc.
— ORPATHYS® plus TAGRISSO® reduced the risk of disease progression or death by 44% in the overall population and 55% in the high MET overexpression population in the first-line setting — — Robust PFS gains alongside very encouraging OS clinical...
Santersus Advances NucleoCapture® into Multinational Pivotal Study in Sepsis
EIN Presswire
Up to 350-patient randomized NUC-CAP study to assess safety, organ support and organ dysfunction in sepsis; Axcellant appointed global CRO to support execution ZURICH, SWITZERLAND, October 22, 2026 /EINPresswire.com/ -- Santersus AG (“Santersus”...
Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema
GlobeNewswire, Inc.
Provides a state-of-the-art overview of the evidence on the critical role of bradykinin B2 receptor in the pathogenesis of bradykinin-mediated angioedema Explains the scientific foundation for targeting the bradykinin B2 receptor as a therapeutic...
European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity
GlobeNewswire, Inc.
PRAGUE and BASEL, Switzerland and BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced that the Boards of Appeal of the European Patent Office (EPO) have upheld...
Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1
GlobeNewswire, Inc.
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease type 1, having met the primary efficacy endpoint, reduction in lesion growth Presentation to include positive update on secondary endpoints, with...
Healthcare IoT Market to Reach US$ 523.1 Billion by 2033, Growing at a CAGR of 21.3% from 2026–2033
EIN Presswire
The Healthcare IoT Market is projected to grow from US$ 135.4 Bn in 2026 to US$ 523.1 Bn by 2033, at a CAGR of 21.3%, driven by smart healthcare adoption BRENTFORD, ENGLAND, UNITED KINGDOM, June 2, 2026 /EINPresswire.com/ -- The global...
Eutopos Pharma Selected to Join Quest for Health as Vidac Pharma Group Expands European Operations
EIN Presswire
Selection supports the establishment of Eutopos Pharma and the Group's growth in Europe's biotech ecosystem.
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
GlobeNewswire, Inc.
Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318 in Alzheimer’s disease LAUSANNE, Switzerland, July 13, 2026 – Vandria, a clinical-stage biotech...
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
GlobeNewswire, Inc.
Randomized Phase 2 study in front-line setting progressing well, with nine sites actively recruiting and patient treatment ongoing Data update expected in 2027, with trial completion in 2028 Trial-in-progress poster to be presented at ESMO 2026 in...
Hawke Media Named Agency of Record for Jacuzzi Group to Drive Next Phase of Growth for its Wellness Brands
EIN Presswire
Partnership builds on more than a decade of collaboration and a shared commitment to innovation, dealer success, and category leadership.
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.